Chicago's South Side Residents Now Have Access to Long-Awaited Sickle Cell Treatment Clinic at Roseland Community Hospital
After six years of initial projections, Chicago's Roseland Community Hospital has finally opened its long-awaited sickle-cell treatment clinic on the city's South Side. The clinic, located on the hospital's fourth floor, offers a range of medical services specifically tailored to address the needs of patients with sickle cell disease.
Sickle cell disease is a blood disorder that affects red blood cells and causes excruciating pain and organ damage. It disproportionately affects African Americans, who often struggle to access timely care. According to the CDC Foundation, there is a severe shortage of physicians trained to treat sickle-cell patients, particularly adults. This results in lengthy waits for patients seeking medical attention, leading to unnecessary emergency department visits.
Roseland Community Hospital's Chief Medical Officer, Dr. Khurram Khan, hailed the clinic as a much-needed resource for the South Side community. "This is not just a clinic; it's a lifeline," he said. The clinic will provide immediate care to patients experiencing sickle-cell pain crises, reducing the need for emergency department visits and improving follow-up care.
The clinic offers various treatments, including hydration therapy, IV pain management, blood transfusions, chelation therapy, comprehensive patient education, and support. Patients aged 16 and older can access these services, which will be staffed by board-certified hematologist-oncologist Dr. Mahoud Mahafzah.
However, the clinic's development was not without its challenges. The initial projected launch date of 2019 was pushed back due to the COVID-19 pandemic, and the hospital faced difficulties in recruiting key medical staff, including a specialist in sickle-cell disease.
According to Khan, being discharged from an emergency department is not the same as being discharged from a specialized clinic like this one. Patients receive proper medication and care plans, which is essential for managing the complex needs of sickle cell patients. The clinic's opening marks a significant step forward in addressing the healthcare disparities faced by African Americans on Chicago's South Side.
After six years of initial projections, Chicago's Roseland Community Hospital has finally opened its long-awaited sickle-cell treatment clinic on the city's South Side. The clinic, located on the hospital's fourth floor, offers a range of medical services specifically tailored to address the needs of patients with sickle cell disease.
Sickle cell disease is a blood disorder that affects red blood cells and causes excruciating pain and organ damage. It disproportionately affects African Americans, who often struggle to access timely care. According to the CDC Foundation, there is a severe shortage of physicians trained to treat sickle-cell patients, particularly adults. This results in lengthy waits for patients seeking medical attention, leading to unnecessary emergency department visits.
Roseland Community Hospital's Chief Medical Officer, Dr. Khurram Khan, hailed the clinic as a much-needed resource for the South Side community. "This is not just a clinic; it's a lifeline," he said. The clinic will provide immediate care to patients experiencing sickle-cell pain crises, reducing the need for emergency department visits and improving follow-up care.
The clinic offers various treatments, including hydration therapy, IV pain management, blood transfusions, chelation therapy, comprehensive patient education, and support. Patients aged 16 and older can access these services, which will be staffed by board-certified hematologist-oncologist Dr. Mahoud Mahafzah.
However, the clinic's development was not without its challenges. The initial projected launch date of 2019 was pushed back due to the COVID-19 pandemic, and the hospital faced difficulties in recruiting key medical staff, including a specialist in sickle-cell disease.
According to Khan, being discharged from an emergency department is not the same as being discharged from a specialized clinic like this one. Patients receive proper medication and care plans, which is essential for managing the complex needs of sickle cell patients. The clinic's opening marks a significant step forward in addressing the healthcare disparities faced by African Americans on Chicago's South Side.